Wilmington, NC11 Active Studies

Myalgic Encephalomyelitis Clinical Trials in Wilmington, NC

Find 11 actively recruiting myalgic encephalomyelitis clinical trials in Wilmington, NC. Connect with local research sites and explore new treatment options.

11
Active Trials
10
Sponsors
3,526
Enrolling

Recruiting Myalgic Encephalomyelitis Studies in Wilmington

About Myalgic Encephalomyelitis Clinical Trials in Wilmington

Myalgic encephalomyelitis (ME/CFS) is a complex, chronic illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and sleep dysfunction. It affects millions worldwide and has no definitive diagnostic test or cure. Research is exploring immune, metabolic, and neurological mechanisms.

There are currently 11 myalgic encephalomyelitis clinical trials recruiting participants in Wilmington, NC. These studies are seeking a combined 3,526 participants. Research is being sponsored by NeuraLight, Children's Oncology Group, CLASSYS Inc. and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myalgic Encephalomyelitis Clinical Trials in Wilmington — FAQ

Are there myalgic encephalomyelitis clinical trials in Wilmington?

Yes, there are 11 myalgic encephalomyelitis clinical trials currently recruiting in Wilmington, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Wilmington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wilmington research site will contact you about next steps.

Are clinical trials in Wilmington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wilmington studies also compensate for your time and travel.

What myalgic encephalomyelitis treatments are being tested?

The 11 active trials in Wilmington are testing new therapies including novel drugs, biologics, and treatment approaches for myalgic encephalomyelitis.

Data updated July 13, 2026 from ClinicalTrials.gov